BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3526798)

  • 1. [HLA and leprosy in Dakar: distribution of histocompatibility antigens in leprous patients and their relationship to ENL reactions].
    Blavy G; Thiam D; Ndoye B; Diakhate L; Millan J
    Acta Leprol; 1986; 4(1):93-9. PubMed ID: 3526798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalances in T cell subpopulations in lepromatous leprosy.
    Wallach D; Cottenot F; Bach MA
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):282-90. PubMed ID: 6216219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; BaliƱa LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigen and susceptibility to leprosy.
    Nakajima S; Kobayashi S; Nohara M; Sato S
    Int J Lepr Other Mycobact Dis; 1977; 45(3):273-7. PubMed ID: 562857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and erythema nodosum leprosum (ENL).
    Agrewala JN; Ghei SK; Sudhakar KS; Girdhar BK; Sengupta U
    Tissue Antigens; 1989 Apr; 33(4):486-7. PubMed ID: 2734777
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressor response in lepromatous leprosy patients: role of Leu 2a cells.
    del Carmen Sasiain M; de la Barrera S; Ruibal-Ares B; Cardama JE; Gatti JC; de Bracco MM
    Immunology; 1987 Jan; 60(1):13-8. PubMed ID: 2950048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histocompatibility antigens in patients with leprosy from Azarbaijan, Iran.
    Mohagheghpour N; Tabatabai H; Mohammad K; Ramanujam K; Modabber FZ
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):597-600. PubMed ID: 122630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lymphocytotoxic activity in leprosy.
    Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
    Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
    Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol precipitates in serum during and after erythema nodosum leprosum--study of their composition and anticomplementary activity.
    Saha K; Chakrabarty AK; Sharma VK; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):44-8. PubMed ID: 6538557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.